Submission Details
| 510(k) Number | K243294 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 18, 2024 |
| Decision Date | February 14, 2025 |
| Days to Decision | 119 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
K243294 is an FDA 510(k) clearance for the Brainomix 360 e-ASPECTS, a Computer-assisted Diagnostic Software For Lesions Suspicious For Cancer (Class II — Special Controls, product code POK), submitted by Brainomix Limited (Oxford, GB). The FDA issued a Cleared decision on February 14, 2025, 119 days after receiving the submission on October 18, 2024. This device falls under the Radiology review panel. Regulated under 21 CFR 892.2060.
| 510(k) Number | K243294 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 18, 2024 |
| Decision Date | February 14, 2025 |
| Days to Decision | 119 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
| Product Code | POK — Computer-assisted Diagnostic Software For Lesions Suspicious For Cancer |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.2060 |
| Definition | Assist Users In Characterizing Lesions Identified On Acquired Medical Images |